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Jackson Champer1,2*, Julie Patel1, Nathalie Fernando1, Elaheh Salehi1, Victoria Wong1 and Jenny Kim1,3Abstract
Propionibacterium acnes and Staphylococcus aureus are cutaneous pathogens that have become increasingly
resistant to antibiotics. We sought to determine if chitosan, a polymer of deacetylated chitin, could be used as a
potential treatment against these bacteria. We found that higher molecular weight chitosan had superior
antimicrobial properties compared to lower molecular weights, and that this activity occurred in a pH dependent
manner. Electron and fluorescence microscopy revealed that chitosan forms aggregates and binds to the surface
of bacteria, causing shrinkage of the bacterial membrane from the cell wall. Of special relevance, clinical isolates of
P. acnes were vulnerable to chitosan, which could be combined with benzoyl peroxide for additive antibacterial
effect. Chitosan also demonstrated significantly less cytotoxicity to monocytes than benzoyl peroxide. Overall,
chitosan demonstrates many promising qualities for treatment of cutaneous pathogens.
Keywords: Chitosan; Benzoyl peroxide; Acne vulgaris; Propionibacterium acnes; Staphylococcus aureus; AntibacterialIntroduction
Chitosan is derived from the partial deacetylation of chi-
tin, a natural polysaccharide composed of β1→ 4 linked
N-acetylglucosamine. It has demonstrated potential as a
vehicle for drug and DNA delivery via nanoparticles
(Singla and Chawla 2001), as a food preserving agent
(No et al 2007), and as a wound dressing for severely
hemorrhaging injuries (Brown et al. 2009). Chitosan is
also known to have antimicrobial activity against viruses
(Kurita 2006), fungi, and bacteria (Rabea et al. 2003),
which combined with its high biocompatibility, low to-
xicity, and ability to biodegrade, make it a promising
candidate for medical use against various pathogens
(Kong et al. 2010). Chitosan has already been shown to
be effective in vivo against bacteria (Lee et al. 2009;
Moon et al. 2007).
Two common cutaneous pathogens, Propionibacte-
rium acnes and Staphylococcus aureus, have increasingly
developed resistance to frontline antibiotics (Song et al.
2011; Patel et al. 2010; Jappe et al. 2008), necessitating
the development of alternative treatments. Benzoyl per-
oxide is a common treatment for acne vulgaris, but it is
highly toxic to human cells, making it less than ideal* Correspondence: jtchamper@yahoo.com
1Division of Dermatology, David Geffen School of Medicine at UCLA, Los
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in any medium, provided the original work is p(Kraft and Freiman 2011). In addition, benzoyl pero-
xide is very irritating, resulting in poor patient com-
pliance. Topical retinoids are also irritating, and oral
isotretinoin, while extremely effective for severe acne,
has significant adverse effects, with restrictions on its
use implemented by the FDA. Therefore, there is a
need to develop novel therapeutics that can effec-
tively treat infectious dermatological diseases without
harmful side effects.
Thus, we sought to determine if chitosan has the po-
tential to act as an effective antibacterial agent against S.
aureus and P. acnes, with a focus on treatment of the
latter, which has been identified as a factor in the patho-
genesis of acne vulgaris (Bellew et al. 2011; Kurokawa
et al. 2009). Additionally, we sought to determine the
parameters to optimize chitosan’s antibacterial proper-
ties and investigated the antibacterial mechanism of chi-
tosan, which is not fully understood.Methods
Materials
Chitosan with 75%+ deacetylation and varying molecular
weight was obtained from Aldrich. Chitosan was added
at 1 mg/mL to 0.01N aqueous HCl, allowed to dissolve,
and then adjusted with NaOH to pH 6. Unless otherwise
specified, experiments were performed with high mo-
lecular weight chitosan (310-375+ kDa).is an Open Access article distributed under the terms of the Creative Commons
g/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction
roperly cited.
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dissolved in DMSO at 10 mg/mL, immediately diluted
to appropriate concentrations, and added to treatments.
Final DMSO concentration was 1%, a concentration
found not to affect results.
8 strains of P. acnes clinical isolates were obtained
from the faces of human volunteers using the tape-strip
method, a protocol approved by the Institutional Review
Board at UCLA.
P. acnes colony-forming unit assay
P. acnes American Type Cell Culture (ATCC) strain
6919 were grown anaerobically at 37°C in Reinforced
Clostridial Media (Oxoid) for 3 days and collected in the
exponential phase of growth by centrifugation. Bacteria
were washed with pH 6 sodium phosphate buffer
supplemented with 0.03% Trypticase Soy Media and
quantified by reading with a spectrophotometer at
600 nm and applying a conversion of ~108 CFU = 1 ab-
sorbance unit. Bacteria were then added to treatments at
107 CFU/mL in a volume of 400 μL and incubated aero-
bically at 37°C for 3 hours. Control samples were un-
treated, and the aerobic incubation was found to have no
effect on bacteria viability. Dilutions were conducted, and
each sample was plated on brucella agar with 5% sheep
blood supplemented with hemin and vitamin K (Remel).
Plates were incubated anaerobically at 37°C for 3 days,
allowing visible P. acnes colonies to form, and colonies
were counted to determine concentration before plating.
S. aureus colony-forming unit assay
S. aureus strain SH1000 were grown overnight at 37°C
in Trypticase Soy Broth (Becton-Dickinson), then diluted
1:50 into fresh media, and collected 3 hours later in the
exponential phase of growth by centrifugation. Bacteria
were washed with pH 6 sodium phosphate buffer
supplemented with 0.03% Trypticase Soy Media and
quantified by reading with a spectrophotometer at
600 nm and applying a conversion of ~5 × 108 CFU = 1
absorbance unit. Bacteria were then added to treatments
at 107 CFU/mL in a volume of 400 μL and incubated
aerobically at 37°C for 3 hours. Control samples were
untreated. Dilutions were conducted, and each sample
was plated on Trypticase Soy Agar. Plates were incu-
bated at 37°C overnight, allowing visible S. aureus col-
onies to form, and colonies were counted to determine
concentration before plating.
Electron microscopy
P. acnes were grown as described above, but treatments
contained 1mL volume with 250 μg/mL chitosan at a con-
centration of 108 bacteria/mL. Bacteria were incubated aer-
obically for one hour at 37°C, washed 3x with PBS
solution, and resuspended in PBS with 2% glutaraldehyde.The samples were fixed with 0.05% osmium tetroxide for 5
minutes, dehydrated in graded ethanol, and embedded in
Eponate 12 (Ted Pella). 60-70 nm sections were cut on a
Reichert-Jung Ultracut E ultramicrotome and picked up on
formvar coated copper grids. The sections were stained
with uranyl acetate and Reynolds lead citrate, and exam-
ined on a JEOL 100CX electron microscope at 80kV.
Fluorescence microscopy
Chitosan was labelled with FITC as conducted previ-
ously (Qaqish and Amiji 1999). Chitosan was dissolved
at 5 mg/mL in 0.1M acetic acid. An equal volume of
methanol with 0.25 mg/mL FITC was slowly added
while stirring. The solution was kept in the dark for one
hour, and then chitosan was precipitated with NaOH.
The chitosan pellet was collected by centrifugation,
washed 3x with water, dissolved at 1 mg/mL in 0.01N
HCl, and adjusted with NaOH to pH 6. P. acnes was
grown and washed as described above, except that
100 μL of 50 mM CTC solution was added to 3mL bac-
teria cultures before harvesting. 100 μg/mL FITC-
labeled chitosan was added to ~107 bacteria/mL, and
viewed one hour later with a Leica Microsystems TCS-
SP2-AOBS Confocal Microscope. An argon 488 nm laser
was used for excitation. Green FITC was viewed through
a 500-535 nm wavelength filter, and red CTC was
viewed through a 599-700 nm wavelength filter.
MTS assay
Blood was drawn from healthy human volunteers
according to a protocol approved by the Institutional Re-
view Board at UCLA. PBMCs were isolated by Ficoll-
Paque (Pharmacia) gradient and allowed to adhere for 2
hours in RPMI media with 1% Fetal Calf Serum (Omega
Scientific) in 96-well plates. Cells were washed 3x with
RPMI media to obtain adherent monocytes. The HaCaT
cell line of keratinocytes were cultured. Cells of both
types were incubated at 37°C with treatment in 100 μL
RPMI media with 10% Fetal Calf Serum (monocytes) or
HaCaT media (keratinocytes) for 16 hours. 20 μL MTS
assay reagent (Promega) was added to each well, and cells
were allowed to incubate for 4 hours at 37°C. The absorb-
ance of each well was read at 490 nm, with absorbance pro-
portional to the number of viable cells (Cory et al. 1991).
Results
Chitosan demonstrates antimicrobial effect against
P. acnes and S. aureus
Chitosan demonstrated a concentration-dependent anti-
microbial activity against both P. acnes and S. aureus
(Figure 1). Chitosan at 5 μg/mL inhibited P. acnes
growth by 2 logs and at 10 μg/mL by close to 3 logs. At
these lower concentrations, chitosan was more effective
at inhibiting P. acnes growth than S. aureus, which was
Figure 1 Chitosan demonstrates antimicrobial effect against P.
acnes and S. aureus. Chitosan was incubated with bacteria for 3
hours to assess antibacterial activity. Bacteria was then enumerated
by colony-forming unit assay to determine concentration, which was
plotted as a percentage of untreated sample. Error bars represent
SEM (n = 4, independent experiments). *p < 0.05 and
**p < 0.01 (t-test).
Figure 2 Molecular weight and pH affect chitosan antibacterial activit
(310-375+ kDa) molecular weight or (C, D) chitosan at different pH was inc
antibacterial activity. Bacteria was then enumerated by colony-forming unit
of untreated sample. Error bars represent SEM (n = 3 for A, C, D, n = 4 for B
(sign test across all concentrations for A, C, D, paired t-test for B).
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At a higher concentration of chitosan (20 μg/mL), chito-
san was effective at inhibiting S. aureus growth with vir-
tually no S. aureus remaining. This may be because S.
aureus remained in exponential growth throughout the
experiment, while P. acnes, an anaerobic species, began
to shift to a static phase. It has been shown chitosan is
most effective against bacteria in the exponential phase
of growth (Chen et al. 2002).
High molecular weight chitosan has greater
antibacterial activity
To determine the effect of molecular weight (MW) on
antibacterial activity, chitosan of low MW (50-190 kDa),
medium MW (190-310 kDa), and high MW (310-375+
kDa) were tested. Concentrations of 2.5, 5, 10, and 20
μg/mL were tested against P. acnes and 5, 10, and 20
μg/mL against S. aureus. Data at 10 μg/mL was typical
of results for all concentrations (Figure 2A-B). Chitosan of
high molecular weight had greater effect against the gram-
positive bacteria P. acnes and S. aureus, with molecular
weight having a more pronounced impact against S. aureus.
Chitosan antibacterial activity is pH dependent
Chitosan was tested against P. acnes and S. aureus at
various pH levels (Figure 2C-D). For P. acnes, which didy. (A, B) Chitosan of low (50-190 kD), medium (190-310 kDa), or high
ubated with (A, C) P. acnes or (B, D) S. aureus for 3 hours to assess
assay to determine concentration, which was plotted as a percentage
, independent experiments). *p < 0.05, **p < 0.01, and ***p < 0.001
Champer et al. AMB Express 2013, 3:37 Page 4 of 8
http://www.amb-express.com/content/3/1/37not multiply during the experiment, chitosan was ob-
served to be more effective at lower pHs, with pH 5.5-
6.5 having indistinguishable activity. An anomalous hook
effect was apparent in all trials at pH 5. Low pH had an
antibacterial effect, but this was small compared to the
effect of chitosan. Chitosan’s positively charged amine
group has a pKa of approximately 6.3, and thus, its solu-
bility falls rapidly in this pH region. The stock chitosan
solutions used had partially precipitated at pH 7, and
fully precipitated at pH 7.5, when the amine group has
minimal positive charge. We observed chitosan to be al-
most completely ineffective at pH 7.5. For S. aureus at
lower pHs, however, we saw chitosan effectiveness gen-
erally decline with reduction in pH, which was corre-
lated with a reduction in the bacterial growth rate for
the duration of the experiment, as determined by un-
treated controls.
Electron microscopy shows chitosan alters cell surface of
P. acnes
Chitosan is thought to exert its antibacterial activity by
disturbing the integrity of the cell membrane. To deter-
mine if a similar mechanism is employed in the killingFigure 3 Electron microscopy shows antibacterial effect. P. acnes bacte
chitosan, and then prepared for electron microscopy. Images were taken a
magnification with 250 nm scale bar (B, D). Figure 4A was modified by mo
of two separate experiments.of P. acnes, we examined chitosan-treated bacteria using
transmission electron microscopy. Micrographs of un-
treated P. acnes illustrate the bacterium's normal surface
architecture, which appears smooth and sharply layered
(Figure 3A-B). In contrast, the chitosan-treated bacteria
lost the integrity of their surface structure, which ap-
pears disturbed, losing its crisp, well-defined structure
(Figure 3C-D). Chitosan bound to the outside of the cell
wall is readily apparent. In addition, we observed the
P. acnes membrane to be shrunken, and out of contact
with the cell wall in places. These images reveal that chi-
tosan perturbs the surface integrity of P. acnes, which
could account for its antimicrobial activity.
Fluorescence confocal microscopy shows
chitosan-bacteria interaction
Cyanoditolyl Tetrazolium Chloride (CTC)-stained P.
acnes was treated with Fluorescein Isothiocyanate
(FITC)-labeled chitosan and examined via fluorescence
microscopy. Untreated bacteria were distributed evenly
in solution (Figure 4A). However, when treated with chi-
tosan, bacteria were clustered into small chitosan parti-
cles (Figure 4B) often visible to the naked eye. Chitosanria were (A, B) left untreated or (C, D) incubated for one hour with
t 19,000x magnification with 1 μm scale bar (A, C) or 72,000x
ving two parts of a larger image together. Images are representative
Figure 4 Fluorescence confocal microscopy shows chitosan-bacteria interaction. CTC-stained P. acnes bacteria were (A) left untreated or
(B, C) incubated for one hour with FITC-labeled chitosan, and then examined by fluorescence microscopy. Scale bar is 2 μm (A, C) or 10 μm (B).
Bacteria is red, while chitosan is green.
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0–50 individual bacteria. All observed bacteria were
bound to these particles. Furthermore, within the par-
ticles of chitosan, P. acnes bacteria were often found
in areas of particularly high chitosan concentration
(Figure 4C). The chitosan appears directly attached to
the surface of the bacteria, where it likely exerts its
antimicrobial action.
Clinical isolates of P. acnes are sensitive to chitosan
To determine potential antimicrobial activity in clinical
settings, we tested chitosan against P. acnes isolates
from 8 different acne patients (Figure 5). All showed
similar vulnerability to chitosan. One strain, B63.1,
demonstrated somewhat more resistance compared toFigure 5 Clinical isolates of P. acnes are sensitive to chitosan.
Chitosan was incubated with different strains of P. acnes for 3 hours
to assess antibacterial activity. Bacteria was then enumerated by
colony-forming unit assay to determine concentration, which was
plotted as a percentage of untreated sample. 8 clinical isolates were
tested, and the most and least susceptible to chitosan are displayed
along with strain ATCC 6919. Error bars represent SEM (n = 3,
independent experiments). **p < 0.01 (paired t-test).P. acnes ATCC strain 6919 at 5 and 10 μg/mL chito-
san, but at 20 μg/mL, all strains were reduced by
nearly 3 logs.Chitosan and benzoyl peroxide have additive
antibacterial activity in combination
Benzoyl peroxide (BP), a common treatment for acne
vulgaris, was tested in combination with chitosan against
P. acnes (Figure 6). Amine groups, particular tertiary
amines, are thought to catalyze the antimicrobial mecha-
nism of benzoyl peroxide (Burkhart and Burkhart
2007), and chitosan has a primary amine group. We found
that BP at 2 μg/mL inhibited P. acnes growth by a half log.Figure 6 Chitosan and benzoyl peroxide have additive
antibacterial activity in combination. Chitosan was incubated
with P. acnes in the presence or absence of benzoyl peroxide for 3
hours to assess antibacterial activity. Bacteria was then enumerated
by colony-forming unit assay to determine concentration, which was
plotted as a percentage of untreated sample. Error bars represent
SEM (n = 3, independent experiments). *p < 0.05, **p < 0.01, and
***p < 0.001 (paired t-test).
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antimicrobial activity against P. acnes.
Chitosan is less toxic to human cells than benzoyl
peroxide
One major adverse effect of benzoyl peroxide as a
treatment for acne vulgaris is its high toxicity to hu-
man cells. Clinically, BP leads to irritation, especially
at a higher concentrations, decreasing patient com-
pliance. We compared the cytotoxicity of chitosan with
BP using a 3-(4,5-dimethylthiazol-2-yl)-5-(3-carboxy-
methoxyphenyl)-2-(4-sulfophenyl)-2H-tetrazolium (MTS)
assay. We found that that chitosan is significantly less
toxic to keratinocytes and primary human monocytes
than benzoyl peroxide (Figure 7). Furthermore, BP con-
centrations of 20–40 μg/mL results in nearly 100% cell
death, but many cells survive when exposed to similar
concentrations of chitosan.
Discussion
As bacteria develop resistance to common antibiotic
therapies, there is a need to develop new treatment op-
tions. This public health issue is clearly evident in acne
vulgaris, which affects over 80% of the population at
some point in their lives. Therefore, we assessed the po-
tential of chitosan as an antimicrobial agent against two
common cutaneous pathogens. In addition, we gathered
data on the antibacterial mechanism of chitosan, and de-
termined how certain properties of chitosan affect its
antibacterial activity.
Chitosan appears to only be effective against bacteria
when dissolved. Due to its pKa of ~6.3, chitosan is only
weakly soluble at neutral pH. We found that chitosan
had little antimicrobial activity above pH 7, so it was ne-
cessary to keep chitosan at sufficiently low pH to en-
hance its antimicrobial effect. It is anticipated that
chitosan is most effective at lower pH when more of the
amine groups are positively charged. Chitosan couldFigure 7 Chitosan is less toxic to human cells than benzoyl peroxide.
chitosan or benzoyl peroxide for 16 hours. Cell viability was then determin
experiments for A, one experiment for B). **p < 0.01, and ***p < 0.001 (t-tethen bind to negatively charged bacterial surface, facili-
tating its antibacterial activity.
By comparing two very different cutaneous pathogens,
we found other factors affect chitosan’s antimicrobial ef-
fectiveness. S. aureus multiplied more quickly when
closest to pH 7 in our experiments. At the same time,
we measured increased chitosan effect against these
more rapidly growing bacteria, as long as the chitosan
remained at least partially dissolved. P. acnes did not
multiply during chitosan treatment, and we found little
effect of pH on antimicrobial activity for dissolved chito-
san. Additionally, chitosan activity was significantly re-
duced against both bacterial species in buffers that did
not include 0.03% Trypticase Soy Media or other nutri-
ents, despite the fact that this media completely precipi-
tates and inactivates chitosan at higher concentrations.
This could potentially be due to a change in bacterial
surface characteristics in response to an environment
devoid of nutrients, hastening transition to a static
growth phase. Moreover, we observed reduced effective-
ness of chitosan with increasing NaCl concentration,
which also slowed S. aureus growth (unpublished data).
Bacterial surface characteristics may account for
chitosan’s improved antimicrobial activity against rapidly
growing bacteria at higher pHs. One study correlated
surface hydrophobicity with chitosan binding (Chung
and Su, 2004). Escherichia coli in the exponential phase
of growth have greater negative surface charge and de-
creased hydrophobicity (Walker et al. 2005), and other
species of bacteria may follow this pattern. This would
allow chitosan to have higher affinity for bacteria in the
exponential phase, and thus, greater activity against
them. However, one study found surface charge and
hydrophobicity largely unchanged between the mid-
exponential and stationary phases in S. aureus (Beck
et al. 1988), while another found variable increase or de-
crease in hydrophobicity between the mid-exponential
and stationary phases depending on strain (Baselga et al.Human monocytes (A) or keratinocytes (B) were incubated with
ed by MTS assay. Error bars represent SEM (n = 3, independent
st).
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increased protonation of surface proteins reducing chito-
san binding at low pH.
Our electron microscopy examination P. acnes under
chitosan treatment was similar to previous results on
gram-positive bacteria (Moon et al. 2007; Raafat et al.
2008; Eaton et al. 2008; Fernandes et al. 2009). We saw
that chitosan adheres to the surface of the bacteria cell
wall, a conclusion supported by our fluorescence micros-
copy study. Additionally, the osmotic pressure-induced
disruption and shrinkage of the bacterial membrane was
consistent with a proposed antibacterial mechanism in-
volving a reduction in the permeability of the membrane
to intracellular components (Young et al. 1982). Indeed,
other studies have shown potassium leakage (Raafat
et al. 2008) as well as protein and nucleotide leakage
(Chung and Chen 2008) in chitosan-treated bacteria.
This mechanism is bactericidal, as opposed to the bac-
teriostatic mechanism of several common antibiotics
used to treat acne, possibly giving chitosan treatment an
advantage.
Another proposed antibacterial mechanism involves
chitosan forming a barrier on the bacterial surface,
preventing entrance of nutrients (Zheng and Zhu 2003).
Higher molecular weight chitosan would be more effe-
tive in this role, which is consistent with our results and
previous results, though only in gram-positive bacteria
(Tayel et al. 2010). Also in support of this mechanism,
we observed bacteria specimens covered with chitosan
via electron microscopy, and bacteria in large aggre-
gates of chitosan via florescence microscopy. It is pos-
sible that chitosan operates against bacteria via multiple
mechanisms.
None of our 8 clinical isolates demonstrated resistance
to chitosan, which has a physical attack mechanism,
rather than affecting the bacterial machinery like con-
ventional antibiotics. Because of this, any developed re-
sistance to chitosan would most likely be nonspecific,
such as a reduction in surface charge or increase in sur-
face hydrophobicity. These changes may reduce bacterial
virulence. Additionally, we have shown that chitosan can
be combined with benzoyl peroxide, which is capable of
destroying drug-resistant bacteria, but irritating. A com-
bined treatment could avoid side effects associated with
highly concentrated benzoyl peroxide, as has been done
previously with other drugs (Zeichner 2012; Taylor and
Shalita 2004).
Major symptoms of acne vulgaris include inflamma-
tion and irritation. To counter these effects, a treatment
for acne vulgaris should be anti-inflammatory. Our pre-
liminary data suggests that in vitro, chitosan does not
reduce induction of inflammatory cytokines in P. acnes-
stimulated monocytes (unpublished data). We have yet
to test the effect of chitosan in other pathways ofinflammation involved in the pathogenesis of acne, in-
cluding the regulation of inflammatory lipids. Indeed,
chitosan has been shown to affect lipid binding (Wydro
et al. 2007) and is currently used as diet supplement.
Furthermore, chitosan has been shown to increase the
permeability of epithelial cell junctions (Smith et al
2004). This could allow treatments with chitosan to
reach deeper into pilosebaceous follicles or dermal
layers. Further studies are warranted to test these prop-
erties in acne and other models of skin infection.
Overall, chitosan has been shown to be effective
against P. acnes and S. aureus under specific conditions
in vitro. To be effective clinically, chitosan activity in
biological environments must be studied. Indeed chem-
ical modification of chitosan has shown some promising
data (Chen and Chou 2005; Mohy Eldin et al. 2008; Ji
et al. 2009). Nevertheless, this is the first study to dem-
onstrate that chitosan has several properties that make it
a very promising choice for effective treatment of P.
acnes infection. Future studies are needed to develop an
effective way to use chitosan in vivo.
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